Skip to main content
. 2020 Jun 25;11(6):486. doi: 10.1038/s41419-020-2689-4

Fig. 4. lncRNA ENST00000563492 promotes BMSCs osteogenesis through CDH11/beta-catenin pathway.

Fig. 4

qRT-PCR analysis of the CDH11 mRNA expression in BMSCs after transfection with Lenti-CDH11 (a) or pLKO.1-CDH11 (b). c Western blot analysis of CDH11 protein expression after transfection with Lenti-CDH11 or pLKO.1-CDH11. d ALP activity and Alizarin Red S staining after BMSCs transfected with Lenti-CDH11 or pLKO.1-CDH11 on the 7th and 14th day. Quantitative analysis of e ALP activity and f Alizarin Red S staining after BMSCs were transfected with Lenti-CDH11 and pLKO.1-CDH11 at the 7th and 14th day. qRT-PCR analysis of OCN (g), RUNX2 (h), and COL1A1 (i) mRNA expression in BMSCs after transfection with Lenti-CDH11 or pLKO.1-CDH11. j Western blot analysis of the beta-catenin protein expression after transfection with Lenti-CDH11 or pLKO.1-CDH11. k ALP activity and Alizarin Red S staining after BMSCs were transfected with Lenti-Vector and Lenti-ENST00000563492 along with pLKO.1-Vector or pLKO.1-CDH11 on the 7th and 14th day. Quantitative analysis of l ALP activity and m Alizarin Red S staining analysis after BMSCs. BMSCs were transfected with Lenti-Vector or Lenti-ENST00000563492 along with pLKO.1-Vector or pLKO.1-CDH11 on the 7th and 14th day. n Western blot analysis of the RUNX2 and beta-catenin protein expression after transfection with Lenti-Vector and Lenti-ENST00000563492. BMSCs isolated from patient no. 1, 2, 5, 12, 10, 14, 19, 20, 21, 22, 23, and 24. All experiments were performed at least three times. The results are presented as mean±SD. *p < 0.05, **p < 0.01.